Biblio

Export 3139 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
A. E. Thomann, Goettel, N., Monsch, R. J., Berres, M., Jahn, T., Steiner, L. A., and Monsch, A. U., The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples., J Alzheimers Dis, vol. 64, no. 2, pp. 643-655, 2018.
K. R. Thomas, Edmonds, E. C., Eppig, J., Salmon, D. P., and Bondi, M. W., Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment., J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
S. Thordardottir and Graff, C., Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation., J Alzheimers Dis, vol. 64, no. s1, pp. S491-S496, 2018.
C. Thygesen, Metaxas, A., Larsen, M. R., and Finsen, B., Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 4, pp. 1247-1259, 2018.
L. Caspar Thygesen, Gimsing, L. N. Ørreslet, Bautz, A., Hvidt, N. Christian, and Johansen, C., Chronic Neurodegenerative Illnesses and Epilepsy in Danish Adventists and Baptists: A Nationwide Cohort Study., J Alzheimers Dis, vol. 56, no. 4, pp. 1429-1435, 2017.
J. René Thyrian, Michalowsky, B., Hertel, J., Wübbeler, M., Gräske, J., Holle, B., Schäfer-Walkmann, S., Wolf-Ostermann, K., and Hoffmann, W., How Does Utilization of Health Care Services Change in People with Dementia Served by Dementia Care Networks? Results of the Longitudinal, Observational DemNet-D-Study., J Alzheimers Dis, vol. 66, no. 4, pp. 1609-1617, 2018.
J. René Thyrian, Eichler, T., Michalowsky, B., Wucherer, D., Reimann, M., Hertel, J., Richter, S., Dreier, A., and Hoffmann, W., Community-Dwelling People Screened Positive for Dementia in Primary Care: A Comprehensive, Multivariate Descriptive Analysis Using Data from the DelpHi-Study., J Alzheimers Dis, vol. 52, no. 2, pp. 609-17, 2016.
J. René Thyrian, Hertel, J., Schulze, L. N., Dörr, M., Prüss, H., Hempel, P., Bimmler, M., Kunze, R., Grabe, H. Jörgen, Teipel, S., and Hoffmann, W., Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study., J Alzheimers Dis, vol. 64, no. 4, pp. 1091-1097, 2018.
T. Tian, Qin, X., Wang, Y., Shi, Y., and Yang, X., 40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice., J Alzheimers Dis, vol. 84, no. 3, pp. 983-993, 2021.
S. Tian, Han, J., Huang, R., Sun, J., Cai, R., Shen, Y., and Wang, S., Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment., J Alzheimers Dis, vol. 58, no. 4, pp. 1163-1173, 2017.
A. Ticinesi, Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Del Rio, D., Ventura, M., Sgoifo, A., and Angelino, D., Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers., J Alzheimers Dis, vol. 86, no. 3, pp. 961-982, 2022.
S. Tiepolt, Schäfer, A., Rullmann, M., Roggenhofer, E., Gertz, H. - J., Schroeter, M. L., Patt, M., Bazin, P. - L., Jochimsen, T. H., Turner, R., Sabri, O., and Barthel, H., Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR., J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
M. Tiihonen, Taipale, H., Tanskanen, A., Tiihonen, J., and Hartikainen, S., Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 127-32, 2016.
A. Tiiman, Luo, J., Wallin, C., Olsson, L., Lindgren, J., Jarvet, J., Per, R., Sholts, S. B., Rahimipour, S., Abrahams, J. Pieter, Karlström, A. Eriksson, Gräslund, A., and Wärmländer, S. K. T. S., Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species., J Alzheimers Dis, vol. 54, no. 3, pp. 971-982, 2016.
A. Tiiman, Jelic, V., Jarvet, J., Järemo, P., Bogdanovic, N., Rigler, R., Terenius, L., Gräslund, A., and Vukojević, V., Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis., J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
M. Timmers, Barão, S., Van Broeck, B., Tesseur, I., Slemmon, J., de Waepenaert, K., Bogert, J., Shaw, L. M., Engelborghs, S., Moechars, D., Mercken, M., Van Nueten, L., Tritsmans, L., De Strooper, B., and Streffer, J. Rolf, BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants., J Alzheimers Dis, vol. 56, no. 4, pp. 1437-1449, 2017.
J. Timsina, Gomez-Fonseca, D., Wang, L., Do, A., Western, D., Álvarez, I., Aguilar, M., Pastor, P., Henson, R. L., Herries, E., Xiong, C., Schindler, S. E., Fagan, A. M., Bateman, R. J., Farlow, M., Morris, J. C., Perrin, R., Moulder, K., Hassenstab, J., Chhatwal, J., Mori, H., Sung, Y. Ju, and Cruchaga, C., Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach., J Alzheimers Dis, vol. 89, no. 1, pp. 193-207, 2022.
M. Toepper, Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience., J Alzheimers Dis, vol. 57, no. 2, pp. 331-352, 2017.
A. Tofiq, Zetterberg, H., Blennow, K., Basun, H., Cederholm, T., Eriksdotter, M., Faxen-Irving, G., Hjorth, E., Jernerén, F., Schultzberg, M., Wahlund, L. - O., Palmblad, J., and Freund-Levi, Y., Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study., J Alzheimers Dis, vol. 83, no. 3, pp. 1291-1301, 2021.
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points., J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
M. Tombini, Sicari, M., Pellegrino, G., Ursini, F., Insardá, P., and Di Lazzaro, V., Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers., J Alzheimers Dis, vol. 54, no. 4, pp. 1619-1627, 2016.
T. Tomoto, Liu, J., Tseng, B. Y., Pasha, E. P., Cardim, D., Tarumi, T., Hynan, L. S., C Cullum, M., and Zhang, R., One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 80, no. 2, pp. 841-853, 2021.
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
Z. Tong, Wang, W., Luo, W., Lv, J., Li, H., Luo, H., Jia, J., and He, R., Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.

Pages